Company Filing History:
Years Active: 2018-2024
Title: The Innovative Contributions of Margaret McCarrick
Introduction
Margaret McCarrick is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of neuroscience and pharmacology. With a total of five patents to her name, she has made remarkable strides in developing compounds that target various neurological disorders.
Latest Patents
Among her latest patents are the "Substituted furanopyrimidine compounds as PDE1 inhibitors." These patents detail chemical entities that have a wide range of applications, including methods for treating neurological disorders, cognitive deficits during stroke rehabilitation, and enhancing neuroprotection and recovery. The compounds are designed to modulate and treat disorders mediated by PDE1 activity or dopaminergic signaling, addressing conditions such as dementia, neurodegenerative diseases, and various peripheral disorders.
Career Highlights
Margaret has worked with notable companies such as Dart Neuroscience and Cayman Ltd. Her work has been instrumental in advancing research and therapeutic strategies in the field of neuroscience. Her innovative approach has led to the development of compounds that not only target specific disorders but also enhance cognitive and motor training efficiency.
Collaborations
Throughout her career, Margaret has collaborated with esteemed colleagues, including James Breitenbucher and Graeme Freestone. These partnerships have fostered a collaborative environment that has contributed to her success and the advancement of her research.
Conclusion
Margaret McCarrick's contributions to the field of neuroscience through her innovative patents and collaborations highlight her as a leading figure in the development of therapeutic strategies for neurological disorders. Her work continues to pave the way for advancements in treatment and recovery.